硕世生物
(688399)
| 流通市值：43.05亿 | | | 总市值：43.05亿 |
| 流通股本：5862.00万 | | | 总股本：5862.00万 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 |
| 每股收益(元) | 0.68 | -6.38 | -3.00 | -1.17 | -0.33 | 31.18 | 27.71 | 21.04 |
| 每股净资产(元) | 58.77 | 58.09 | 61.46 | 63.30 | 64.12 | 64.45 | 60.98 | 54.31 |
| 每股资本公积金(元) | 13.76 | 13.76 | 13.76 | 13.76 | 13.75 | 13.75 | 13.75 | 13.75 |
| 每股未分配利润(元) | 43.51 | 42.83 | 46.20 | 48.04 | 48.87 | 49.20 | 45.73 | 39.07 |
| 每股经营性现金流(元) | 0.90 | -1.93 | -4.73 | -6.64 | -3.86 | 33.52 | 22.56 | 14.53 |
| 净资产收益率(%) | 1.17 | -10.41 | -4.77 | -1.82 | -0.52 | 58.80 | 52.60 | 40.37 |
| 营业总收入(元) | 9111.94万 | 4.03亿 | 2.76亿 | 1.87亿 | 9405.37万 | 55.35亿 | 42.93亿 | 32.66亿 |
营业总收入同比增长(%) | -3.12 | -92.72 | -93.56 | -94.29 | -93.82 | 94.95 | 97.69 | 188.88 | | 归属净利润(元) | 4006.80万 | -37381.14万 | -17601.43万 | -6829.47万 | -1942.40万 | 18.28亿 | 16.24亿 | 12.34亿 |
| 归属净利润同比增长(%) | 306.28 | -120.45 | -110.84 | -105.54 | -103.08 | 53.19 | 63.06 | 145.71 |
| 扣非净利润(元) | 1487.41万 | -42920.11万 | -20529.74万 | -9168.52万 | -3429.25万 | 17.66亿 | 16.05亿 | 12.23亿 |
|
| 扣非净利润同比增长(%) | 143.37 | -124.31 | -112.79 | -107.50 | -105.49 | 54.93 | 62.84 | 147.59 |
| 毛利率(%) | 70.93 | 63.91 | 60.12 | 64.74 | 65.20 | 60.62 | 60.66 | 60.39 |
| 净利率(%) | 43.97 | -92.72 | -63.67 | -36.60 | -20.65 | 33.03 | 37.83 | 37.77 |
| 资产负债率(%) | 14.58 | 12.83 | 15.94 | 14.69 | 20.29 | 22.75 | 23.14 | 28.89 |
| 存货周转率(次) | 0.27 | 0.88 | 0.53 | 0.28 | 0.14 | 8.96 | 4.70 | 3.32 |